EACC - A novel reversible autophagy inhibitor

EACC - A novel reversible autophagy inhibitor

EACC affects the translocation of SNAREs Stx17 and SNAP29 on autophagosomes without impeding the completion of autophagosomes. EACC treatment also reduces the interaction of Stx17 with the HOPS subunit VPS33A and the cognate lysosomal R-SNARE VAMP8. Interestingly, this effect of EACC although quite robust is reversible and hence EACC can be used as a tool to study autophagosomal SNARE trafficking.

EACC inhibits autophagy by preventing SNARE Stx17 loading on autophagosomes